AstraZeneca PLC (AZN) vs Linde plc (LIN)
AZN leads on 13 of 17 compared metrics.
A side-by-side comparison of AstraZeneca PLC and Linde plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs LIN
growth of $100 · last 30yAZN +732.9%LIN +2454.0%LIN compounded faster
AZN LIN
AZN vs LIN: by the numbers
- •AZN is the larger company ($277.22B vs $242.20B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 34.77 P/E).
- •LIN converts more revenue to profit (20.56% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 4.55% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 1.18%).
Which is better, AZN or LIN?
Metric tally: AZN 13 · LIN 4It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | LIN |
|---|---|---|
| P/E ratio | 26.92● | 34.77 |
| Forward P/E | 15.33● | 26.71 |
| P/S ratio | 4.62● | 7.05 |
| P/B ratio | 5.90● | 6.33 |
| PEG ratio | 0.14● | 4.12 |
| EV / EBITDA | 14.92● | 21.65 |
| FCF yield | 2.89%● | 2.09% |
Profitability
| Metric | AZN | LIN |
|---|---|---|
| Gross margin | 81.68%● | 45.99% |
| Operating margin | 23.69% | 28.79%● |
| Net margin | 17.19% | 20.56%● |
| ROE | 21.95%● | 18.47% |
| ROIC | 13.03%● | 8.97% |
Dividends
| Metric | AZN | LIN |
|---|---|---|
| Dividend yield | 1.79%● | 1.18% |
| Payout ratio | 48.48% | 42.26% |
Growth (annualized)
| Metric | AZN | LIN |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 4.55% |
| EPS CAGR (5Y) | 22.02% | 25.30%● |
| FCF CAGR (5Y) | 15.68%● | 1.07% |
| Total return CAGR (5Y) | 11.03% | 13.97%● |
Frequently asked
- Which is better, AZN or LIN?
- It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 13 to 4.
- Is AZN or LIN cheaper?
- On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and LIN at 34.77.
- Which has grown faster, AZN or LIN?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus LIN at 4.55%.
- Does AZN or LIN pay a bigger dividend?
- AZN yields 1.79% and LIN yields 1.18% based on trailing dividends and the latest price.
- Is AZN or LIN more profitable?
- LIN runs the higher net margin — AZN at 17.19% versus LIN at 20.56%.
- Which has been the better investment, AZN or LIN?
- Over the past 10-year, LIN delivered the higher annualized total return — AZN at 15.77% versus LIN at 18.46%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioLinde P/E ratioAstraZeneca dividend yieldLinde dividend yieldAstraZeneca ROELinde ROEAstraZeneca operating marginLinde operating marginAstraZeneca revenue growthLinde revenue growthAstraZeneca free cash flowLinde free cash flow
AstraZeneca & Linde appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.